Procurement of three varieties produced by nine enterprises was suspended, amlodipine besylate tablets, montmorillonite powder
-
Last Update: 2018-12-21
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On December 19, Jiangsu public resources trading center issued the notice on suspending the purchase of drugs that failed to pass the quality and efficacy consistency evaluation of generic drugs The suspended purchase includes amlodipine besylate tablets, montmorillonite powder, and rosuvastatin calcium tablets (film coating), which are produced by nine enterprises, involving Sinopharm Rongsheng pharmaceutical, Jiangsu Yabang Epson pharmaceutical, Guangzhou Baiyunshan Pharmaceutical Group, Zhejiang hailisheng pharmaceutical, Shandong LVYE pharmaceutical, etc The details are as follows: Annex
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
